Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TELA Bio, Inc.TELA · Entity 7381 | Director | July 15, 2026 | July 17, 2026 |
| Vyome Holdings, IncOBLN · Entity 1824 | Director | September 16, 2020 | September 18, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TELA Bio, Inc.
Report date July 15, 2026 · Filed July 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 44,530 |
Reported balance
After 2026-07-15 transaction · row 1
1 source rowRow 1 · 2026-07-15 · Grant · Acquired 20,930 · Balance 44,530 F1: Represents shares of common stock issued in lieu of cash compensation under the Issuer's Amended and Restated Non-Employee Director Compensation Policy. All shares are fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock issued in lieu of cash compensation under the Issuer's Amended and Restated Non-Employee Director Compensation Policy. All shares are fully vested.
Vyome Holdings, Inc
Report date September 16, 2020 · Filed September 18, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Expires 2030-09-16 | Direct | 27,250 |
Reported balance
After 2020-09-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-09-16 · Grant · Acquired 27,250 · Balance 27,250 F1: Each share of Common Stock underlying the cash-settled Option represents the right to a cash payment equal to the excess, if any, of (i) the Fair Market Value of each such share on the date of exercise over (ii) the exercise price per share set forth in the Notice of Stock Option Grant ($0.77), and such Option shall vest as to 1/36th of the shares of Common Stock underlying the Option on each monthly anniversary of the grant date, subject to the Grantee's continued service with the Company through the applicable vesting date. This Option may not be exercised for shares of the Company's Common Stock. F2: The Option shall vest as to 1/36th of the shares of Common Stock underlying the Option on each monthly anniversary of the grant date, subject to the Grantee's continued service with the Company through the applicable vesting date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.77 · Expires 2030-09-16 | Direct | 27,250 |
Reported balance
After 2020-09-16 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-09-16 · Grant · Acquired 27,250 · Balance 27,250 F2: The Option shall vest as to 1/36th of the shares of Common Stock underlying the Option on each monthly anniversary of the grant date, subject to the Grantee's continued service with the Company through the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of Common Stock underlying the cash-settled Option represents the right to a cash payment equal to the excess, if any, of (i) the Fair Market Value of each such share on the date of exercise over (ii) the exercise price per share set forth in the Notice of Stock Option Grant ($0.77), and such Option shall vest as to 1/36th of the shares of Common Stock underlying the Option on each monthly anniversary of the grant date, subject to the Grantee's continued service with the Company through the applicable vesting date. This Option may not be exercised for shares of the Company's Common Stock.
F2: The Option shall vest as to 1/36th of the shares of Common Stock underlying the Option on each monthly anniversary of the grant date, subject to the Grantee's continued service with the Company through the applicable vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 15, 2026 Filed Jul 17, 2026 21:30 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantCommon Stock | 20,930 | $0.79 | $16,430.05 |
DisclosureSEC source: 0001685640-26-000003 · form4-07172026_050703.xml · nonDerivative · entry 1 Plovanic William J. · CIK 0001685640 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,530 F1 · shares: Represents shares of common stock issued in lieu of cash compensation under the Issuer's Amended and Restated Non-Employee Director Compensation Policy. All shares are fully vested. Read SEC document |
| June 09, 2026 Filed Jun 11, 2026 22:09 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantStock Option (Right to Buy) · Derivative | 17,335 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001685640-26-000001 · form4-06112026_100629.xml · derivative · entry 2 Plovanic William J. · CIK 0001685640 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,335 Underlying: Common Stock · 17,335 shares Expires 2036-06-09 F2 · derivative.exercise_date: The option vests on the earlier of (a) June 9, 2027, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 09, 2026 Filed Jun 11, 2026 22:09 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantCommon Stock | 11,675 | $0.00 | $0.00 |
DisclosureSEC source: 0001685640-26-000001 · form4-06112026_100629.xml · nonDerivative · entry 1 Plovanic William J. · CIK 0001685640 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,600 F1 · shares: These restricted stock units vest on the earlier of (a) June 9, 2027, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| October 31, 2025 Filed Nov 3, 2025 21:22 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantStock Option (Right to Buy) · Derivative | 17,550 | $0.00 Strike: $1.23 | $0.00 |
DisclosureSEC source: 0001685640-25-000006 · form4-11032025_091130.xml · derivative · entry 2 Plovanic William J. · CIK 0001685640 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,550 Underlying: Common Stock · 17,550 shares Expires 2035-10-31 F2 · derivative.exercise_date: The option vests in 36 equal monthly installments on each monthly anniversary of October 31, 2025, in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| October 31, 2025 Filed Nov 3, 2025 21:22 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantCommon Stock | 11,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001685640-25-000006 · form4-11032025_091130.xml · nonDerivative · entry 1 Plovanic William J. · CIK 0001685640 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,925 F1 · shares: These restricted stock units will vest in three equal annual installments beginning on October 31, 2026, in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| September 16, 2020 Filed Sep 18, 2020 23:44 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | GrantStock Option (Right to Buy) · Derivative | 27,250 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001214659-20-007966 · marketforms-49701.xml · derivative · entry 2 Plovanic William J. · CIK 0001685640 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,250 Underlying: Common Stock · 27,250 shares Expires 2030-09-16 F2 · derivative.exercise_date: The Option shall vest as to 1/36th of the shares of Common Stock underlying the Option on each monthly anniversary of the grant date, subject to the Grantee's continued service with the Company through the applicable vesting date. Read SEC document |
| September 16, 2020 Filed Sep 18, 2020 23:44 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | GrantStock Option · Derivative | 27,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-20-007966 · marketforms-49701.xml · derivative · entry 1 Plovanic William J. · CIK 0001685640 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,250 Underlying: Common Stock · 27,250 shares Expires 2030-09-16 F1 · derivative.exercise_price: Each share of Common Stock underlying the cash-settled Option represents the right to a cash payment equal to the excess, if any, of (i) the Fair Market Value of each such share on the date of exercise over (ii) the exercise price per share set forth in the Notice of Stock Option Grant ($0.77), and such Option shall vest as to 1/36th of the shares of Common Stock underlying the Option on each monthly anniversary of the grant date, subject to the Grantee's continued service with the Company through the applicable vesting date. This Option may not be exercised for shares of the Company's Common Stock. F2 · derivative.exercise_date: The Option shall vest as to 1/36th of the shares of Common Stock underlying the Option on each monthly anniversary of the grant date, subject to the Grantee's continued service with the Company through the applicable vesting date. Read SEC document |
| January 24, 2020 Filed Jan 28, 2020 21:30 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | GrantRestricted Stock Units · Derivative | 441,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-20-000643 · marketforms-47578.xml · derivative · entry 1 Plovanic William J. · CIK 0001685640 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 441,125 Underlying: Common Stock · 441,125 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of the Issuer's common stock, the cash equivalent thereof, or a combination of both, based on the achievement of stock price goals over a three-year performance period ending December 31, 2022. F1 · derivative.exercise_date: Each restricted stock unit represents a right to receive one share of the Issuer's common stock, the cash equivalent thereof, or a combination of both, based on the achievement of stock price goals over a three-year performance period ending December 31, 2022. F1 · derivative.expiration_date: Each restricted stock unit represents a right to receive one share of the Issuer's common stock, the cash equivalent thereof, or a combination of both, based on the achievement of stock price goals over a three-year performance period ending December 31, 2022. Read SEC document |
| November 12, 2019 Filed Nov 14, 2019 13:30 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | PurchaseCommon Stock | 65,000 | $1.66 | $107,822.00 |
DisclosureSEC source: 0001214659-19-007137 · marketforms-46130.xml · nonDerivative · entry 1 Plovanic William J. · CIK 0001685640 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,806 F1 · kind: The transaction reported on this Form 4 is an open market purchase of Obalon Stock on November 12, 2019 by William Plovanic, totaling $107,822. Read SEC document |
| October 25, 2019 Filed Oct 28, 2019 20:31 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $1.75 | $0.00 |
DisclosureSEC source: 0001214659-19-006665 · marketforms-45992.xml · derivative · entry 1 Plovanic William J. · CIK 0001685640 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-10-25 F1 · derivative.exercise_date: The Option shall vest as to (i) 25% of the shares of Common Stock underlying the Stock Option on October 19, 2020 and (ii) 1/48th of the shares of Common Stock underlying the Stock Option on each monthly anniversary of October 19, 2020 thereafter, subject to the grantee's continued service with the Company through the applicable vesting date. Read SEC document |
| August 06, 2019 Filed Aug 8, 2019 18:27 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | PurchaseWarrants (Right to Buy) · Derivative | 9,375 | $0.00 Strike: $4.40 | $0.00 |
DisclosureSEC source: 0001214659-19-005088 · marketforms-45430.xml · derivative · entry 2 Plovanic William J. · CIK 0001685640 · Director · President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,375 Underlying: Common Stock · 9,375 shares Expires 2024-08-06 Read SEC document |
| August 06, 2019 Filed Aug 8, 2019 18:27 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | PurchaseCommon Stock | 12,500 | $4.00 | $50,000.00 |
DisclosureSEC source: 0001214659-19-005088 · marketforms-45430.xml · nonDerivative · entry 1 Plovanic William J. · CIK 0001685640 · Director · President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,806 F1 · price: Reflects price paid to underwriters in Issuer's registered offering. F2 · balance_after: Includes Restricted Shares that are subject to vesting. Read SEC document |
| July 23, 2019 Filed Jul 25, 2019 20:30 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | GrantStock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $0.96 | $0.00 |
DisclosureSEC source: 0001214659-19-004753 · marketforms-45370.xml · derivative · entry 1 Plovanic William J. · CIK 0001685640 · Director · President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2029-07-23 F1 · derivative.exercise_date: The option shall vest as to 1/48th of the shares underlying the option on each monthly anniversary of May 20, 2019, subject to Mr. Plovanic's continued status as a service provider with the Issuer through the applicable vesting date. F2 · derivative.underlying_shares: Share amounts do not reflect the impact of a 1-for-10 reverse stock split that became effective after the grant date for the options referenced herein. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 23:30 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0001214659-19-000150 · marketforms-43640.xml · derivative · entry 1 Plovanic William J. · CIK 0001685640 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2029-01-02 F1 · derivative.exercise_date: The Option shall vest as to 1/48th of the Shares underlying the Option on each monthly anniversary of the Grant Date, subject to the grantee's continued status as a Service Provider with the Company through the applicable vesting date. Read SEC document |
| August 23, 2018 Filed Aug 28, 2018 01:32 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | GrantCommon Stock | 27,472 | $1.82 | $49,999.04 |
DisclosureSEC source: 0001214659-18-005735 · marketforms-42784.xml · nonDerivative · entry 1 Plovanic William J. · CIK 0001685640 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,044 F1 · shares: The reporting person purchased these shares directly from the issuer in a private placement. F2 · balance_after: Includes Restricted Shares that are subject to vesting. Read SEC document |
| May 15, 2018 Filed May 17, 2018 23:18 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | GrantCommon Stock (Restricted Stock Award) | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-18-003871 · marketforms-42031.xml · nonDerivative · entry 1 Plovanic William J. · CIK 0001685640 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 F1 · shares: The Restricted Shares shall vest as to 100% of the Shares underlying the Award on January 2, 2020, subject to the reporting person's provision of service to the Issuer. Read SEC document |
| March 14, 2018 Filed Mar 15, 2018 22:15 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | PurchaseCommon Stock | 5,412 | $4.04 | $21,842.83 |
DisclosureSEC source: 0001214659-18-002171 · marketforms-41497.xml · nonDerivative · entry 4 Plovanic William J. · CIK 0001685640 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By wife IRA Disclosed balance after: 15,000 F2 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $3.99 to $4.05, inclusive. Read SEC document |
| March 14, 2018 Filed Mar 15, 2018 22:15 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | PurchaseCommon Stock | 5,300 | $4.04 | $21,386.56 |
DisclosureSEC source: 0001214659-18-002171 · marketforms-41497.xml · nonDerivative · entry 2 Plovanic William J. · CIK 0001685640 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By IRA Disclosed balance after: 15,000 F2 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $3.99 to $4.05, inclusive. Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 22:15 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | PurchaseCommon Stock | 9,588 | $4.05 | $38,824.69 |
DisclosureSEC source: 0001214659-18-002171 · marketforms-41497.xml · nonDerivative · entry 3 Plovanic William J. · CIK 0001685640 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By wife IRA Disclosed balance after: 9,588 F1 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $4.015 to $4.05, inclusive. Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 22:15 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | PurchaseCommon Stock | 9,700 | $4.05 | $39,276.27 |
DisclosureSEC source: 0001214659-18-002171 · marketforms-41497.xml · nonDerivative · entry 1 Plovanic William J. · CIK 0001685640 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By IRA Disclosed balance after: 9,700 F1 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $4.015 to $4.05, inclusive. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 21:13 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $7.15 | $0.00 |
DisclosureSEC source: 0001214659-18-000188 · marketforms-40646.xml · derivative · entry 1 Plovanic William J. · CIK 0001685640 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2028-01-02 F1 · derivative.exercise_date: The Option shall vest as to 1/48th of the Shares underlying the Option on each monthly anniversary of the Grant Date, subject to the grantee's continued status as a Service Provider with the Company through the applicable vesting date. In addition, any portion of the Option that vests will not be exercisable until Mr. Plovanic relocates his primary residence to within 35 miles of the Company's headquarters (at the time of the relocation), provided that such relocation must occur no later than the second anniversary of the Grant Date. The Option will automatically expire if Mr. Plovanic does not satisfy this requirement prior to or on the second anniversary of the Grant Date. Read SEC document |
| November 09, 2016 Filed Nov 14, 2016 22:42 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | GrantStock Option (right to buy) · Derivative | 55,000 | $0.00 Strike: $8.74 | $0.00 |
DisclosureSEC source: 0001209191-16-149825 · doc4.xml · derivative · entry 1 Plovanic William J. · CIK 0001685640 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2026-11-09 F1 · derivative.exercise_date: The option vests as to 25% of the total shares on March 7, 2017, and then 2.0833% of the total shares monthly thereafter, with 100% of the total shares vested on March 7, 2020, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.